{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:32:46Z","timestamp":1790771566108,"version":"4.1.0"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T00:00:00Z","timestamp":1670112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejmech.2022.115002","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:14:19Z","timestamp":1670246059000},"page":"115002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases"],"prefix":"10.1016","volume":"246","author":[{"given":"Andreina","family":"Henriquez-Figuereo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mor\u00e1n-Serradilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Angulo-Elizari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Sanmart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8266-0445","authenticated-orcid":false,"given":"Daniel","family":"Plano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.115002_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001334","article-title":"Neglected tropical diseases and the sustainable development goals: an urgent call for action from the front line","volume":"4","author":"Addisu","year":"2019","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.ejmech.2022.115002_bib2","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1371\/journal.pmed.0030102","article-title":"Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV\/AIDS, tuberculosis, and malaria","volume":"3","author":"Hotez","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2022.115002_bib3","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2012.13727","article-title":"Neglected tropical diseases: diagnosis, clinical management, treatment and control","volume":"142","author":"Utzinger","year":"2012","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.ejmech.2022.115002_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40249-020-0630-9","article-title":"Neglected tropical diseases: an effective global response to local poverty-related disease priorities","volume":"9","author":"Engels","year":"2020","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.ejmech.2022.115002_bib6","article-title":"World neglected tropical diseases day","volume":"14","author":"Hotez","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2022.115002_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004521","article-title":"Preventive chemotherapy versus innovative and intensified disease management in neglected tropical diseases: a distinction whose shelf life has expired","volume":"10","author":"Rosenberg","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2022.115002_bib8","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(03)14694-6","article-title":"The trypanosomiases","volume":"362","author":"Barrett","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2022.115002_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2022.115002_bib11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijpara.2005.07.001","article-title":"The current status of zoonotic leishmaniases and approaches to disease control","volume":"35","author":"Gramiccia","year":"2005","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2022.115002_bib12","doi-asserted-by":"crossref","unstructured":"A. Taghipour, A.A.-O. Abdoli, A. Ramezani, A. Abolghazi, M.A. Mofazzal Jahromi, S. Maani, S.M. Heidar Nejadi, S. Rasti, M. Shams, E. Ghasemi, Leishmaniasis and trace element alterations: a systematic review, Biol. Trace Elem. Res.., 199 3918-3938.","DOI":"10.1007\/s12011-020-02505-0"},{"key":"10.1016\/j.ejmech.2022.115002_bib13","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1017\/S0031182009006416","article-title":"Controlling sleeping sickness: a review","volume":"136","author":"Welburn","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2022.115002_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/B978-0-12-398457-9.00004-4","article-title":"Priorities for the elimination of sleeping sickness","volume":"79","author":"Welburn","year":"2012","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.ejmech.2022.115002_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.meegid.2018.05.033","article-title":"Tsetse fly evolution, genetics and the trypanosomiases - a review","volume":"64","author":"Krafsur","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ejmech.2022.115002_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1474-4422(12)70296-X","article-title":"Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)","volume":"12","author":"Kennedy","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2022.115002_bib17","first-page":"231","article-title":"History of sleeping sickness (African trypanosomiasis)","volume":"18","author":"Cox","year":"2004","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.ejmech.2022.115002_bib18","doi-asserted-by":"crossref","first-page":"15 4629","DOI":"10.3390\/molecules26154629","article-title":"An overview on target-based drug design against kinetoplastid protozoan infections: human African trypanosomiasis, Chagas Disease and Leishmaniases","volume":"26","author":"Kourbeli","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.115002_bib19","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.7150\/ijbs.24612","article-title":"Review of drug repositioning approaches and resources","volume":"14","author":"Xue","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115002_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.115002_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.therap.2020.02.006","article-title":"Drug repurposing in rare diseases: myths and reality","volume":"75","author":"Fetro","year":"2020","journal-title":"Therapie"},{"key":"10.1016\/j.ejmech.2022.115002_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41564-019-0357-1","article-title":"Drug repurposing for antimicrobial discovery","volume":"4","author":"Farha","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ejmech.2022.115002_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111660","article-title":"Multi-target drugs active against leishmaniasis: a paradigm of drug repurposing","volume":"183","author":"Braga","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib24","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/cmdc.201700259","article-title":"Repurposing of human kinase inhibitors in neglected protozoan diseases","volume":"12","author":"Dichiara","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.115002_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258292","article-title":"Drug repurposing for Chagas disease: in vitro assessment of nimesulide against trypanosoma cruzi and insights on its mechanisms of action","volume":"16","author":"Trindade","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.115002_bib26","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.115002_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10822-011-9518-x","article-title":"A very short history of structure-based design: how did we get here and where do we need to go?","volume":"26","author":"Blaney","year":"2012","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2022.115002_bib28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.drudis.2011.02.011","article-title":"State-of-the-art in ligand-based virtual screening","volume":"16","author":"Ripphausen","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2022.115002_bib29","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2174\/156802612800166756","article-title":"A review of QSAR studies to discover new drug-like compounds actives against leishmaniasis and trypanosomiasis","volume":"12","author":"Alberto Castillo-Garit","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib30","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.drudis.2016.06.021","article-title":"Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective","volume":"21","author":"Ferreira","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2022.115002_bib31","first-page":"1","article-title":"Introduction to fragment-based drug discovery","volume":"317","author":"Erlanson","year":"2012","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib32","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2174\/1568026621666210804115700","article-title":"Perspectives on fragment-based drug discovery: a strategy applicable to diverse targets","volume":"21","author":"Li","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tips.2012.02.006","article-title":"Experiences in fragment-based drug discovery","volume":"33","author":"Murray","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2022.115002_bib34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fmolb.2020.00180","article-title":"Application of fragment-based drug discovery to versatile targets","volume":"7","author":"Li","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2022.115002_bib35","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.2174\/1568026619666181130134250","article-title":"Counting on fragment based drug design approach for drug discovery","volume":"18","author":"Kashyap","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/147120","article-title":"Natural products for medicine","author":"Shibata","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ejmech.2022.115002_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/np068054v","article-title":"Natural products as sources of new drugs over the last 25 years","volume":"70","author":"Newman","year":"2007","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.115002_bib38","doi-asserted-by":"crossref","first-page":"23 5769","DOI":"10.3390\/molecules25235769","article-title":"Biological activities of natural products","volume":"25","author":"Ekiert","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.115002_bib39","doi-asserted-by":"crossref","first-page":"4 911","DOI":"10.3390\/molecules25040911","article-title":"Selected fungal natural products with antimicrobial properties","volume":"25","author":"Jakubczyk","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.115002_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103922","article-title":"Recent progress of antibacterial natural products: future antibiotics candidates","volume":"101","author":"Dai","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1039\/c0np00069h","article-title":"Natural products and Chagas' disease: a review of plant compounds studied for activity against trypanosoma cruzi","volume":"28","author":"Izumi","year":"2011","journal-title":"Nat. Prod. Rep."},{"issue":"6","key":"10.1016\/j.ejmech.2022.115002_bib42","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-0030-1250411","article-title":"Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems","volume":"77","author":"Hannaert","year":"2011","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2022.115002_bib43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00436-020-07035-1","article-title":"Anti-leishmanial and anti-trypanosomal natural products from endophytes","volume":"120","author":"Hzounda Fokou","year":"2021","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2022.115002_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/biom9110679","article-title":"Natural products and synthetic analogs as a source of antitumor drugs","volume":"9","author":"Sharifi-Rad","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2022.115002_bib45","volume":"vol. 17","author":"Khalifa","year":"2019"},{"key":"10.1016\/j.ejmech.2022.115002_bib46","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.copbio.2021.02.001","article-title":"Antifungal natural products","volume":"69","author":"Heard","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ejmech.2022.115002_bib47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/molecules25010006","article-title":"Growing importance of natural products research","volume":"25","author":"Drasar","year":"2019","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.ejmech.2022.115002_bib48","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1002\/ptr.7099","article-title":"Natural products: a lead for drug discovery and development","volume":"35","author":"Chopra","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2022.115002_bib49","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nchem.1100","article-title":"Under sulfur's spell","volume":"3","author":"Rauchfuss","year":"2011","journal-title":"Nat. Chem."},{"issue":"1 5","key":"10.1016\/j.ejmech.2022.115002_bib50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s41061-018-0184-5","article-title":"Analysis of US FDA-approved drugs containing sulfur atoms","volume":"376","author":"Scott","year":"2018","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/j.1537-2197.1925.tb05817.x","article-title":"The effect of selenium compounds upon growth and germination in plants","volume":"12","author":"Levine","year":"1925","journal-title":"Am. J. Bot."},{"key":"10.1016\/j.ejmech.2022.115002_bib52","first-page":"111","article-title":"The nutritional relationships of selenium","volume":"9","author":"Watts","year":"1994","journal-title":"J. Orthomol. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115002_bib53","first-page":"225","article-title":"The properties, functions, and use of selenium compounds in living organisms","volume":"30","author":"Bodnar","year":"2012","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115002_bib54","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00204-021-03003-5","article-title":"Toxicology and pharmacology of synthetic organoselenium compounds: an update","volume":"95","author":"Nogueira","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2022.115002_bib55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/bmj.2.3067.463-a","article-title":"A Preliminary note on the treatment of inoperable carcinoma with selenium","volume":"2","author":"Watson-Williams","year":"1919","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejmech.2022.115002_bib56","first-page":"1","article-title":"Selenium for preventing cancer","volume":"1","author":"Vinceti","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9 874","key":"10.1016\/j.ejmech.2022.115002_bib57","first-page":"1","article-title":"Seleno-metabolites and their precursors: a new dawn for several illnesses?","volume":"12","author":"Mor\u00e1n-Serradilla","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2022.115002_bib58","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2174\/138955708785740625","article-title":"Selenium compounds and apoptotic modulation: a new perspective in cancer therapy","volume":"8","author":"Sanmart\u00edn","year":"2008","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s42000-019-00125-5","article-title":"Selenium intake, status, and health: a complex relationship","volume":"19","author":"Rayman","year":"2020","journal-title":"Hormones (Basel)"},{"issue":"30","key":"10.1016\/j.ejmech.2022.115002_bib60","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.2174\/092986711797379249","article-title":"Selenium and clinical trials: new therapeutic evidence for multiple diseases","volume":"18","author":"Carmen Sanmart\u00edn","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00436-021-07400-8","article-title":"Selenium and protozoan parasitic infections: selenocompounds and selenoproteins potential","volume":"121","author":"Rashidi","year":"2022","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2022.115002_bib62","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1039\/c0ob00086h","article-title":"Tellurium: an element with great biological potency and potential","volume":"8","author":"Ba","year":"2010","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1749-6632.1972.tb52572.x","article-title":"Some developments in organic tellurium chemistry","volume":"192","author":"Petragnani","year":"1972","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2022.115002_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22115924","article-title":"Tellurium: a rare element with influence on prokaryotic and eukaryotic biological systems","volume":"22","author":"Vavrova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.115002_bib65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02785282","article-title":"Biochemistry of tellurium","volume":"55","author":"Taylor","year":"1996","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.ejmech.2022.115002_bib66","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1070\/RC1998v067n03ABEH000370","article-title":"Organic derivatives of monocoordinated tellurium","volume":"67","author":"Igor D.Sadekov","year":"1998","journal-title":"Russ. Chem. Rev."},{"key":"10.1016\/j.ejmech.2022.115002_bib67","unstructured":"CDC (23\/07)."},{"key":"10.1016\/j.ejmech.2022.115002_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104316","article-title":"Novel anti-tubercular and antibacterial based benzosuberone-thiazole moieties: synthesis, molecular docking analysis, DNA gyrase supercoiling and ATPase activity","volume":"104","author":"Omar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib69","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejmech.2016.05.050","article-title":"New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi","volume":"121","author":"Paulo Andr\u00e9 Teixeira de Moraes Gomes","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib70","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1080\/14786419.2019.1648459","article-title":"Synthesis of new 1,3-thiazol derivatives of maleopimaric acid as anticancer, antibacterial and antifungal agents","volume":"35","author":"Sultanova","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2022.115002_bib71","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1016\/j.bmcl.2016.07.010","article-title":"Design, synthesis and antimalarial evaluation of novel thiazole derivatives","volume":"26","author":"Bueno","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.115002_bib72","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2174\/1573406412666160201121310","article-title":"Antibacterial activity, interaction with nucleobase and molecular docking studies of 4-formylbenzoic acid based thiazoles","volume":"12","author":"Krzysztof Z Laczkowski","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib73","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.bmcl.2017.03.069","article-title":"6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases","volume":"27","author":"Thompson","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.115002_bib74","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejmech.2016.01.010","article-title":"Phthalimido-thiazoles as building blocks and their effects on the growth and morphology of trypanosoma cruzi","volume":"111","author":"Paulo Andr\u00e9 Teixeira de Moraes Gomes","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib75","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bmc.2016.02.027","article-title":"Compound profiling and 3D-QSAR studies of hydrazone derivatives with activity against intracellular trypanosoma cruzi","volume":"24","author":"L\u00edvia Bandeira Costa","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2016.04.010","article-title":"Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds","volume":"117","author":"Maria V Papadopoulou","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib77","article-title":"Synthesis and trypanocidal activity of novel pyridinyl-1,3,4-thiadiazole derivatives","volume":"127","author":"J.M.C.B","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.115002_bib78","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2017.02.026","article-title":"Desing and synthesis of potent anti-trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death","volume":"130","author":"Elany Barbosa da Silva","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib79","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1573406412666160909152614","article-title":"Thio- and semicarbazones: hope in the search for treatment of leishmaniasis and chagas disease","volume":"13","author":"Silva","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109514","article-title":"Structural design, synthesis and anti-trypanosoma cruzi profile of the second generation of 4-thiazolidinones chlorine derivatives","volume":"345","author":"Bezerra de Oliveira Filho","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2022.115002_bib81","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ejmech.2018.01.043","article-title":"Aryl thiosemicarbazones for the treatment of trypanosomatidic infections","volume":"146","author":"Linciano","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib82","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/07391102.2016.1176603","article-title":"Application of bioisosterism in design of the semicarbazone derivatives as cruzain inhibitors: a theoretical and experimental study","volume":"35","author":"Vital","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2022.115002_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.591570","article-title":"Antiparasitic behavior of trifluoromethylated pyrazole 2-amino-1,3,4-thiadiazole hybrids and their analogues: synthesis and structure-activity relationship","volume":"11","author":"Camargo","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.115002_bib84","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/1573406415666190620141109","article-title":"The use of sulfonamide derivatives in the treatment of trypanosomatid parasites including trypanosoma cruzi, trypanosoma brucei, and Leishmania ssp","volume":"16","author":"Scarim","year":"2020","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib85","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.bmcl.2018.04.064","article-title":"Identification and preliminary structure-activity relationship studies of novel pyridyl sulfonamides as potential Chagas disease therapeutic agents","volume":"28","author":"Peres","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.115002_bib86","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/j.bmc.2017.09.042","article-title":"Binding of triazole-linked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasion","volume":"25","author":"Marchiori","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib87","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejmech.2017.03.063","article-title":"An in vitro and in vivo evaluation of new potential trans-sialidase inhibitors of Trypanosoma cruzi predicted by a computational drug repositioning method","volume":"132","author":"Lara-Ramirez","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib88","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14756366.2017.1405264","article-title":"Nanoemulsions of sulfonamide carbonic anhydrase inhibitors strongly inhibit the growth of Trypanosoma cruzi","volume":"33","author":"Vermelho","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib89","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/14756366.2019.1626375","article-title":"Appraisal of anti-protozoan activity of nitroaromatic benzenesulfonamides inhibiting carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani","volume":"34","author":"Nocentini","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib90","article-title":"A new chemotype with promise against Trypanosoma cruzi","volume":"30","author":"Wang","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.115002_bib91","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.3390\/molecules24173077","article-title":"Facile synthesis of a series of non-symmetric thioethers including a benzothiazole moiety and their use as efficient in vitro anti-trypanosoma cruzi agents","volume":"24","author":"Avila-Sorrosa","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.115002_bib92","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1039\/D0MD00072H","article-title":"Synthesis of quinone imine and sulphur-containing compounds with antitumor and trypanocidal activities: redox and biological implications","volume":"11","author":"Almeida","year":"2020","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.ejmech.2022.115002_bib93","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1128\/AAC.01788-15","article-title":"Phenotypic screening in vitro of novel aromatic amidines against Trypanosoma cruzi","volume":"60","author":"Simoes-Silva","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.115002_bib94","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1016\/j.bmc.2016.07.013","article-title":"Design, synthesis, molecular docking and biological evaluation of thiophen-2-iminothiazolidine derivatives for use against Trypanosoma cruzi","volume":"24","author":"Silva-Junior","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib95","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2014.08.012","article-title":"2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation","volume":"86","author":"Cardoso","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib96","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1128\/AAC.47.10.3368-3370.2003","article-title":"Activity of megazol, a trypanocidal nitroimidazole, is associated with DNA damage","volume":"47","author":"Enanga","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.115002_bib97","first-page":"613","article-title":"Thiadiazoles: the appropriate pharmacological scaffolds with leishmanicidal and antimalarial activities: a review","volume":"20","author":"Tahghighi","year":"2017","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.ejmech.2022.115002_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2017.05.005","article-title":"In vitro evaluation of cytotoxicity and leishmanicidal activity of phthalimido-thiazole derivatives","volume":"105","author":"Alian\u00e7a","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2022.115002_bib99","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00436-020-06706-3","article-title":"Antileishmanial activity evaluation of thiazolidine-2,4-dione against Leishmania infantum and Leishmania braziliensis","volume":"119","author":"Fl\u00e1vio Simas Moreira Neri","year":"2020","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2022.115002_bib100","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pt.2007.08.019","article-title":"Target assessment for antiparasitic drug discovery","volume":"23","author":"Frearson","year":"2007","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2022.115002_bib101","first-page":"539","volume":"384","author":"Krauth-Siegel","year":"2003","journal-title":"The parasite-specific trypanothione metabolism of Trypanosoma and Leishmania"},{"key":"10.1016\/j.ejmech.2022.115002_bib102","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molbiopara.2015.11.003","article-title":"Thiol redox biology of trypanosomatids and potential targets for chemotherapy","volume":"206","author":"Leroux","year":"2016","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2022.115002_bib103","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/acsinfecdis.8b00355","article-title":"Pyrrolopyrimidine vs imidazole-phenyl-thiazole scaffolds in nonpeptidic dimerization inhibitors of leishmania infantum trypanothione reductase","volume":"5","author":"Revuelto","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.115002_bib104","series-title":"Developments in Diagnosis and Antileishmanial Drugs","author":"Bhargava","year":"2012"},{"key":"10.1016\/j.ejmech.2022.115002_bib105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jgar.2020.02.028","article-title":"Study of in vitro biological activity of thiazoles on Leishmania (Leishmania) infantum","volume":"22","author":"Vin\u00edcius Vasconcelos Gomes de Oliveira","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ejmech.2022.115002_bib106","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1016\/j.bmc.2019.07.009","article-title":"2-(Bipiperidin-1-yl)-5-(nitroaryl)-1,3,4-thiadiazoles: synthesis, evaluation of in vitro leishmanicidal activity, and mechanism of action","volume":"27","author":"Mojallal-Tabatabaei","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib107","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.saa.2016.11.046","article-title":"Spectroscopic, single crystal X-ray, hirshfeld, in vitro and in silico biological evaluation of a new series of potent thiazole nucleus integrated with pyrazoline scaffolds","volume":"174","author":"Salian","year":"2017","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejmech.2022.115002_bib108","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2013.06.049","article-title":"Synthesis of novel analogs of 2-pyrazoline obtained from [(7-chloroquinolin-4-yl)amino]chalcones and hydrazine as potential antitumor and antimalarial agents","volume":"67","author":"Insuasty","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib109","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1039\/C4MD00238E","article-title":"Design, synthesis and molecular docking of novel bipyrazolyl thiazolone scaffold as a new class of antibacterial agents","volume":"5","author":"Kalaria","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2022.115002_bib110","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.bmc.2016.03.032","article-title":"Synthesis, anti-inflammatory, analgesic, COX-1\/2 inhibition activities and molecular docking study of pyrazoline derivatives","volume":"24","author":"Abdel-Sayed","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib111","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejmech.2014.12.055","article-title":"A novel series of thiazolyl\u2013pyrazoline derivatives: synthesis and evaluation of antifungal activity, cytotoxicity and genotoxicity","volume":"92","author":"Alt\u0131ntop","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib112","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00044-011-9661-x","article-title":"Synthesis, antimicrobial, antioxidant, anti-inflammatory, and analgesic activities of some new 3-(2\u2032-thienyl)pyrazole-based heterocycles","volume":"21","author":"Abdel-Wahab","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2022.115002_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900351","article-title":"New thiazolyl-pyrazoline derivatives bearing nitrogen mustard as potential antimicrobial and antiprotozoal agents","volume":"353","author":"Cuartas","year":"2020","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2022.115002_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900325","article-title":"Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds","volume":"353","author":"Istanbullu","year":"2020","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2022.115002_bib115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bioorg.2018.12.025","article-title":"Synthesis of novel quinoline-based thiadiazole, evaluation of their antileishmanial potential and molecular docking studies","volume":"85","author":"Almandil","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126725","article-title":"Synthesis and antileishmanial evaluation of thiazole orange analogs","volume":"30","author":"Abdelhameed","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.115002_bib117","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.biopha.2016.05.038","article-title":"Antitumor and immunomodulatory activities of thiosemicarbazones and 1,3-thiazoles in jurkat and HT-29 cells","volume":"82","author":"dos Santos","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.115002_bib118","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1021\/jm900552r","article-title":"Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors","volume":"52","author":"Yu","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib119","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1021\/tx800182k","article-title":"Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity","volume":"21","author":"Opletalov\u00e1","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2022.115002_bib120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2009.11.004","article-title":"Strand transfer inhibitors of HIV-1 integrase: bringing IN a new era of antiretroviral therapy","volume":"85","author":"McColl","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2022.115002_bib121","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1016\/S0960-894X(02)00703-5","article-title":"Synthesis and in vitro antiprotozoal activity of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazone derivatives","volume":"12","author":"Bharti","year":"2002","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.115002_bib122","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1021\/jm801585u","article-title":"2-acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity","volume":"52","author":"Richardson","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib123","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejmech.2016.07.014","article-title":"Arylthiosemicarbazones as antileishmanial agents","volume":"123","author":"Manzano","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib124","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ejmech.2018.04.003","article-title":"Anti-leishmanial click modifiable thiosemicarbazones: design, synthesis, biological evaluation and in silico studies","volume":"151","author":"Temraz","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/biom9110643","article-title":"Evaluation of novel chalcone-thiosemicarbazones derivatives as potential anti-Leishmania amazonensis agents and its HSA binding studies","volume":"9","author":"Mendes","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2022.115002_bib126","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2019.06.051","article-title":"Synthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio)semicarbazides as a novel class of anti-leishmanial agents","volume":"179","author":"Eldehna","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib127","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1016\/j.bmcl.2017.06.053","article-title":"Antileishmanial potential of fused 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiols: synthesis, biological evaluations and computational studies","volume":"27","author":"Patil","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.115002_bib128","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molstruc.2018.11.017","article-title":"Synthesis and comparison of antileishmanial and cytotoxic activities of S-(\u2212)-limonene benzaldehyde thiosemicarbazones with their R-(+)-analogues","volume":"1179","author":"Almeida Batista","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2022.115002_bib129","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4155\/fmc-2017-0120","article-title":"Synthesis, modeling and biological evaluation of hybrids from pyrazolo[1,5c]pyrimidine as antileishmanial agents","volume":"9","author":"Atta","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/14756366.2016.1250755","article-title":"Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives","volume":"32","author":"Saccoliti","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib131","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2016.10.017","article-title":"Quinoline derivatives: synthesis, leishmanicidal activity and involvement of mitochondrial oxidative stress as mechanism of action","volume":"260","author":"Coimbra","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2022.115002_bib132","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/acsmedchemlett.8b00347","article-title":"Nongenotoxic 3-nitroimidazo[1,2-a]pyridines are NTR1 substrates that display potent in vitro antileishmanial activity","volume":"10","author":"Fersing","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.115002_bib133","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.biopha.2011.01.003","article-title":"Synthesis of 4-aminoquinoline analogues and their platinum(II) complexes as new antileishmanial and antitubercular agents","volume":"65","author":"Carmo","year":"2011","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.115002_bib134","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.biopha.2011.03.003","article-title":"4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents","volume":"65","author":"de Souza","year":"2011","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.115002_bib135","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3390\/molecules22122041","article-title":"Synthesis and evaluation of thiochroman-4-one derivatives as potential leishmanicidal agents","volume":"22","author":"Vargas","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.115002_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112668","article-title":"Antikinetoplastid SAR study in 3-nitroimidazopyridine series: identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties","volume":"206","author":"Fersing","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib137","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2174\/1389557520666200715104555","article-title":"A Review on anticancer activities of thiophene and its analogs","volume":"20","author":"Mishra","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib138","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5897\/AJPP2016.4401","article-title":"Screening of some pyrazole derivatives as promising antileishmanial agent","volume":"11","author":"Abdu","year":"2017","journal-title":"Afr J Pharm Pharmacol"},{"key":"10.1016\/j.ejmech.2022.115002_bib139","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejmech.2016.08.048","article-title":"Synthesis and evaluation against Leishmania amazonensis of novel pyrazolo[3,4-d]pyridazinone-N-acylhydrazone-(bi)thiophene hybrids","volume":"124","author":"Jacomini","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib140","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1016\/j.bmc.2016.04.057","article-title":"Antileishmanial activity of new thiophene-indole hybrids: design, synthesis, biological and cytotoxic evaluation, and chemometric studies","volume":"24","author":"Felix","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib141","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1016\/j.bmcl.2018.08.040","article-title":"Synthesis and biological evaluation of isoxazolyl-sulfonamides: a non-cytotoxic scaffold active against trypanosoma cruzi, leishmania amazonensis and herpes simplex virus","volume":"28","author":"da Rosa","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.115002_bib142","first-page":"365","article-title":"Experimental chemotherapy of schistosomiasis XII. active derivatives of aminoethanethiosulfuric acids","volume":"18","author":"Nelson","year":"1976","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.ejmech.2022.115002_bib143","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5935\/0103-5053.19900006","article-title":"Synthesis of potential Schistosomicides: new 2-(alkylamino)-1-octometiosulfuric acids","volume":"1","author":"Oliveira Penido","year":"1990","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.115002_bib144","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1590\/S0074-02761994000400017","article-title":"Schistosomicidal activity of alkylaminooctanethiosulfuric acids","volume":"89","author":"Penido","year":"1994","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2022.115002_bib145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2007.05.028","article-title":"A new series of schistosomicide drugs, the alkylaminoalkanethiosulfuric acids, partially inhibit the activity of Schistosoma mansoni ATP diphosphohydrolase","volume":"570","author":"Luiz Oliveira Penido","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.115002_bib146","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/jphp.13163","article-title":"The alkylaminoalkanethiosulfuric acids exhibit in-vitro antileishmanial activity against Leishmania (Viannia) braziliensis: a new perspective for use of these schistosomicidal agents","volume":"71","author":"Porcino","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.115002_bib147","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1016\/j.bmc.2006.01.034","article-title":"Synthesis, docking, and in vitro activity of thiosemicarbazones, aminoacyl-thiosemicarbazides and acyl-thiazolidones against Trypanosoma cruzi","volume":"14","author":"Leite","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib148","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1080\/17460441.2017.1388370","article-title":"Recent developments with rhodanine as a scaffold for drug discovery","volume":"12","author":"Kaminskyy","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.115002_bib149","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejmech.2017.09.031","article-title":"5-Ene-4-thiazolidinones: an efficient tool in medicinal chemistry","volume":"140","author":"Kaminskyy","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejmech.2016.02.030","article-title":"Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole\/pyrazoline\u2013thiazolidine-based hybrids","volume":"113","author":"Havrylyuk","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib151","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bioorg.2019.01.045","article-title":"Synthesis of 5-enamine-4-thiazolidinone derivatives with trypanocidal and anticancer activity","volume":"86","author":"Holota","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib152","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2174\/1568026615666150915111741","article-title":"Sulfur containing scaffolds in drugs: synthesis and application in medicinal chemistry","volume":"16","author":"Feng","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib153","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.bmcl.2017.01.043","article-title":"Antiparasitic lethality of sulfonamidebenzamides in kinetoplastids","volume":"27","author":"Hackler","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.115002_bib154","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejmech.2015.11.043","article-title":"Design, synthesis and antitrypanosomal activities of 2,6-disubstituted-4,5,7-trifluorobenzothiophenes","volume":"108","author":"Bhambra","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejmech.2015.12.040","article-title":"New approach towards the synthesis of selenosemicarbazones, useful compounds for Chagas' disease","volume":"109","author":"Pizzo","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112673","article-title":"Selenium as an interesting option for the treatment of Chagas disease: a review","volume":"206","author":"Alcolea","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib157","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3390\/ph14050419","article-title":"Library of selenocyanate and diselenide derivatives as in vivo antichagasic compounds targeting trypanosoma cruzi mitochondrion","volume":"14","author":"Martin-Escolano","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2022.115002_bib158","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1021\/acsinfecdis.1c00048","article-title":"Selenium derivatives as promising therapy for Chagas Disease: in vitro and in vivo studies","volume":"7","author":"Martin-Escolano","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.115002_bib159","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.1016\/j.bmc.2017.10.016","article-title":"Selenium-containing analogues of WC-9 are extremely potent inhibitors of Trypanosoma cruzi proliferation","volume":"25","author":"Chao","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib160","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1002\/ejoc.202000216","article-title":"Electrochemical selenation\/cyclization of quinones: a Rapid, Green and efficient access to functionalized trypanocidal and antitumor compounds","author":"Kharma","year":"2020","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib161","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/1062936X.2020.1848914","article-title":"QSAR and molecular docking modelling of anti-leishmanial activities of organic selenium and tellurium compounds","volume":"32","author":"Cabrera","year":"2021","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.ejmech.2022.115002_bib162","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ejmech.2014.09.088","article-title":"Selenium analogues of raloxifene as promising antiproliferative agents in treatment of breast cancer","volume":"87","author":"Arsenyan","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib163","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1007\/s12011-020-02505-0","article-title":"Leishmaniasis and trace element alterations: a systematic review","volume":"199","author":"Taghipour","year":"2021","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.ejmech.2022.115002_bib164","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1016\/j.ejmech.2011.04.054","article-title":"Selenocyanates and diselenides: a new class of potent antileishmanial agents","volume":"46","author":"Plano","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib165","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00590-21","article-title":"New phosphoramidates containing selenium as leishmanicidal agents","volume":"65","author":"Etxebeste-Mitxeltorena","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.115002_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127371","article-title":"Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates","volume":"30","author":"Garnica","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.115002_bib167","doi-asserted-by":"crossref","unstructured":"Y. Baquedano, V. Alcolea, \u00c1. Toro Miguel, J. Guti\u00e9rrez Killian, P. Nguewa, M. Font, E. Moreno, S. Espuelas, A. Jim\u00e9nez-Ruiz, A. Palop Juan, D. Plano, C. Sanmart\u00edn, Novel heteroaryl selenocyanates and diselenides as potent antileishmanial agents, Antimicrob. Agents Chemother., 60 3802-3812.","DOI":"10.1128\/AAC.02529-15"},{"key":"10.1016\/j.ejmech.2022.115002_bib168","first-page":"63","article-title":"Leishmanicidal Activity of isoselenocyanate derivatives","author":"Fernandez-Rubio","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.115002_bib169","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3390\/molecules25081924","article-title":"Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases","volume":"25","author":"Battista","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.115002_bib170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.115002_bib171","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1111\/febs.15720","article-title":"Functional partnership between carbonic anhydrase and malic enzyme in promoting gluconeogenesis in Leishmania major","volume":"288","author":"Mondal","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2022.115002_bib172","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bioorg.2019.01.069","article-title":"Discovery of new organoselenium compounds as antileishmanial agents","volume":"86","author":"Al-Tamimi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib173","first-page":"712","article-title":"Synthesis, in silico Study and antileishmanial Evaluation of new selenides derived from 7-chloro-quinoline and N-phenylacetamides","volume":"32","author":"Huang","year":"2021","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.115002_bib174","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molbiopara.2016.03.002","article-title":"Selenoproteins of African trypanosomes are dispensable for parasite survival in a mammalian host","volume":"206","author":"Bonilla","year":"2016","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2022.115002_bib175","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijpddr.2017.08.001","article-title":"Diglycosyl diselenides alter redox homeostasis and glucose consumption of infective African trypanosomes","volume":"7","author":"Franco","year":"2017","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ejmech.2022.115002_bib176","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1096\/fj.06-7500com","article-title":"Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models","volume":"21","author":"Sredni","year":"2007","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2022.115002_bib177","doi-asserted-by":"crossref","first-page":"436","DOI":"10.18632\/aging.100468","article-title":"The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes","volume":"4","author":"Halperin-Sheinfeld","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ejmech.2022.115002_bib178","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00018-017-2653-3","article-title":"Ammonium trichloro [1,2-ethanediolato-O,O\u2032]-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K\/Akt pathway","volume":"75","author":"Vishwakarma","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2022.115002_bib179","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1021\/acs.jmedchem.0c00211","article-title":"Tellurides bearing sulfonamides as novel inhibitors of leishmanial carbonic anhydrase with potent antileishmanial activity","volume":"63","author":"Angeli","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib180","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1021\/acsmedchemlett.9b00060","article-title":"Diacetal ditellurides as highly active and selective antiparasitic agents toward Leishmania amazonensis","volume":"10","author":"Bandeira","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.115002_bib181","doi-asserted-by":"crossref","first-page":"21346","DOI":"10.1021\/acsomega.9b02948","article-title":"Synthesis of calix-salen silver corates for evaluation of their antimicrobial and anticancer activities","volume":"4","author":"Roy","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2022.115002_bib182","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.msec.2019.01.107","article-title":"Homoleptic and heteroleptic silver(I) complexes bearing diphosphane and thioamide ligands: synthesis, structures, DNA interactions and antibacterial activity studies","volume":"99","author":"Varna","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejmech.2022.115002_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2019.110872","article-title":"New polynuclear 1,5-naphthyridine-silver(I) complexes as potential antimicrobial agents: the key role of the nature of donor coordinated to the metal center","volume":"203","author":"\u0110uri\u0107","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2022.115002_bib184","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1248\/cpb.58.1569","article-title":"Anticonvulsant activity and toxicity evaluation of Cu(II) and Zn(II) metal complexes derived from triazole-quinoline ligands","volume":"58","author":"Kulkarni","year":"2010","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2022.115002_bib185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jinorgbio.2017.06.017","article-title":"Synthesis and anti-diabetic activity of new N,N-dimethylphenylenediamine-derivatized nitrilotriacetic acid vanadyl complexes","volume":"177","author":"Niu","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2022.115002_bib186","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1002\/cmdc.201800474","article-title":"Gold(I)\u2013coumarin\u2013caffeine-based complexes as new potential anti-inflammatory and anticancer trackable agents","volume":"13","author":"Trommenschlager","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.115002_bib187","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4155\/fmc-2017-0248","article-title":"Amyloid \u03b2-targeted metal complexes for potential applications in alzheimer's disease","volume":"10","author":"Liu","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173746","article-title":"An overview of viruses discovered over the last decades and drug development for the current pandemic","volume":"890","author":"Mirza","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.115002_bib189","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/1573409915666190827163327","article-title":"Characterization of the trypanosoma brucei pteridine reductase active-site using computational docking and virtual screening techniques","volume":"16","author":"Shamshad","year":"2020","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.ejmech.2022.115002_bib190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejmech.2014.07.092","article-title":"Trends in research of antitrypanosomal agents among synthetic heterocycles","volume":"85","author":"Kryshchyshyn","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib191","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ejmech.2018.05.044","article-title":"Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases","volume":"155","author":"Ravera","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib192","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00775-013-1024-2","article-title":"Metal-drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cells","volume":"18","author":"Iniguez","year":"2013","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114834","article-title":"Metal-based compounds containing selenium: an appealing approach towards novel therapeutic drugs with anticancer and antimicrobial effects","volume":"244","author":"Ramos-Inza","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: the first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib195","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejmech.2015.07.009","article-title":"Ferroquine and its derivatives: new generation of antimalarial agents","volume":"101","author":"Wani","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115002_bib196","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.2174\/0929867328666210917114912","article-title":"Insight into recent drug discoveries against trypanosomatids and plasmodium spp parasites: new metal-based compounds","volume":"29","author":"Scarim","year":"2022","journal-title":"Curr. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:48:59Z","timestamp":1759330139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422009047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":194,"alternative-id":["S0223523422009047"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115002","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115002"}}